Clinical trial
Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia…
NCT00288353 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00288353 |
|---|---|
| Title | Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes |
| Official title | Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Bipolar Disorder |
| Intervention type | Drug |
| Interventions | aripiprazole (Abilify), ziprasidone (Geodon) |
| Enrollment | 48 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Feb 7, 2006 |
| Last update posted | Oct 2, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: